Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

HopeAI

AI-powered clinical evidence for drug development and precision medicine
2023
02-Oct
02-10
Princeton, New Jersey, United States
  • Drug Discovery and Development
  • Healthcare
  • Personalized Medicine Technologies

Innovation

Industry Problem

Clinical trials are slowed by fragmented data, manual patient matching, and underrepresentation of diverse populations.

R&D Focus

AI-powered clinical evidence for drug development and precision medicine

Innovative Solution

At HopeAI, we are on a mission to bring hope to patients by accelerating the clinical development of new treatments through AI. This AI copilot will work alongside the clinical development team to make swift and data-optimized decisions throughout trial design and execution, enhancing probability of success and expediting time to market.

Investment Funding

Last Funding Stage

Pre-Seed

Total Funding Amount

1.1M

Last Funding Date

14-08-2024

Startup Stage

Seed

Lead Investors

Plug and Play, Taihill Venture, PKSHA Capital

About

At HopeAI, we are on a mission to bring hope to patients by accelerating the clinical development of new treatments through AI. Patients cannot wait. We believe AI-enabled clinical trials are the key to bringing life-saving medicines to patients faster and more efficiently. Our initial approach involves crafting an AI copilot with up-to-date clinical evidence and profound statistical insights. This AI copilot will work alongside the clinical development team to make swift and data-optimized decisions throughout trial design and execution, enhancing probability of success and expediting time to market. As AI continues to advance, we envision a future where all promising drug candidates can be rapidly tested in AI-enabled clinical trials and made accessible to patients in need. We are committed to paving the ‘highway’ for clinical trials.

Products

Demo Product or Complete Product?

Clinical-stage

Something missing or incorrect on this page? Help us enrich this information